International Journal of Clinical Case Reports, 2025, Vol.15, No.4, 190-199 http://medscipublisher.com/index.php/ijccr 199 Riese P., Trittel S., Akmatov M., May M., Prokein J., Illig T., Schindler C., Sawitzki B., Elfaki Y., Floess S., Huehn J., Błażejewski A., Strowig T., Hernández-Vargas E., Geffers R., Zhang B., Li Y., Pessler F., and Guzmán C., 2022, Distinct immunological and molecular signatures underpinning influenza vaccine responsiveness in the elderly, Nature Communications, 13(1): 6894. https://doi.org/10.1038/s41467-022-34487-z Sadarangani S., Young B., Lian W., Phua H., Chen M., Barr I., Yeo T., Dalan R., and Chow A., 2022, DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults, NPJ Vaccines, 7(1): 135. https://doi.org/10.1038/s41541-022-00548-z Santoro A., Bientinesi E., and Monti D., 2021, Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?, Ageing Research Reviews, 71: 101422. https://doi.org/10.1016/j.arr.2021.101422 Sato Y., and Yanagita M., 2019, Immunology of the ageing kidney, Nature Reviews Nephrology, 15: 625-640. https://doi.org/10.1038/s41581-019-0185-9 Smetana J., Chlibek R., Shaw J., Špliňo M., and Prymula R., 2018 Influenza vaccination in the elderly, Human Vaccines and Immunotherapeutics, 14: 540-549. https://doi.org/10.1080/21645515.2017.1343226 Song J., Cheong H., Hwang I., Choi W., Jo Y., Park D., Cho G., Hwang T., and Kim W., 2010, Long-term immunogenicity of influenza vaccine among the elderly: risk factors for poor immune response and persistence, Vaccine, 28(23): 3929-3935. https://doi.org/10.1016/j.vaccine.2010.03.067 Sugishita Y., Nakayama T., Sugawara T., and Ohkusa Y., 2020, Negative effect on immune response of repeated influenza vaccination and waning effectiveness in interseason for elderly people, Vaccine, 38(21): 3759-3765. https://doi.org/10.1016/j.vaccine.2020.03.025 Veroniki A., Thirugnanasampanthar S., Konstantinidis M., Dourka J., Ghassemi M., Neupane D., Khan P., Nincic V., Corry M., Robson R., Parker A., Soobiah C., Sinilaite A., Doyon-Plourde P., Gil A., Siu W., Moqueet N., Stevens A., English K., Florez I., Yepes-Nunez J., Hutton B., Muller M., Moja L., Straus S., and Tricco A., 2024, Trivalent and quadrivalent seasonal influenza vaccine in adults aged 60 and older: a systematic review and network meta-analysis, BMJ Evidence-Based Medicine, 29: 239-254. https://doi.org/10.1136/bmjebm-2023-112767 Ward B., Makarkov A., Séguin A., Pillet S., Trépanier S., Dhaliwall J., Libman M., Vesikari T., and Landry N., 2020, Efficacy immunogenicity and safety of a plant-derived quadrivalent virus-like particle influenza vaccine in adults (18-64 years) and older adults (≥65 years): two multicentre randomised phase 3 trials, The Lancet, 396: 1491-1503. https://doi.org/10.1016/S0140-6736(20)32014-6 Weinberger B., Herndler-Brandstetter D., Schwanninger A., Weiskopf D., and Grubeck‐Loebenstein B., 2008, Biology of immune responses to vaccines in elderly persons, Clinical Infectious Diseases, 46(7): 1078-1084. https://doi.org/10.1086/529197 Wilkinson K., Wei Y., Szwajcer A., Rabbani R., Zarychanski R., Abou-Setta A., and Mahmud S., 2017, Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis, Vaccine, 35(21): 2775-2780. https://doi.org/10.1016/j.vaccine.2017.03.092 Williams K., Geffel M., Alcorn J., Nowalk M., Levine M., Kim S., Flannery B., Susick M., and Zimmerman R., 2022, Factors associated with humoral immune response in older adults who received egg-free influenza vaccine, Vaccine ,41(3): 862-869. https://doi.org/10.1016/j.vaccine.2022.12.041 Wang W., 2024, Studying the dynamic changes of the immune system through single-cell omics, International Journal of Molecular Medical Science, 14(1): 29-41. https://doi.org/10.5376/ijmms.2024.14.0005
RkJQdWJsaXNoZXIy MjQ4ODYzNA==